The estimated Net Worth of Jack D. Boyle is at least $18.6 mil dollars as of 2 April 2021. Mr. Boyle owns over 22,962 units of Endo International plc stock worth over $18,608 and over the last 5 years he sold ENDP stock worth over $0. In addition, he makes $0 as Senior Vice President - Financial Planning & Analysis, Chief Accounting Officer y Controller at Endo International plc.
Jack has made over 2 trades of the Endo International plc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 22,962 units of ENDP stock worth $6,719 on 2 April 2021.
The largest trade he's ever made was exercising 22,962 units of Endo International plc stock on 2 April 2021 worth over $6,719. On average, Jack trades about 4,478 units every 58 days since 2020. As of 2 April 2021 he still owns at least 63,595 units of Endo International plc stock.
You can see the complete history of Mr. Boyle stock trades at the bottom of the page.
Jack D. Boyle serves as Senior Vice President - Financial Planning & Analysis, Chief Accounting Officer, Controller of the Company. Mr. Boyle joined Endo in 2007 as Financial Reporting Manager and assumed various roles of increasing responsibility, most recently serving as Senior Vice President, Financial Planning and Analysis since February 2018. Previously, he served as Vice President, Finance - Branded Pharmaceuticals from November 2016 until February 2018; Vice President, Finance for Endo’s International Unit from August 2014 until November 2016; Senior Director, FP&A from March 2011 until August 2014; and Director, Internal Audit from January 2008 until March 2011. Prior to joining Endo, Mr. Boyle served as a public accountant for Ernst & Young LLP from 1997 until 2007. Mr. Boyle is a licensed certified public accountant in the Commonwealth of Pennsylvania, and holds a Bachelor of Science degree in accounting from Bucknell University and an MBA from the Leonard N. Stern School of Business at New York University.
Jack Boyle is 44, he's been the Senior Vice President - Financial Planning & Analysis, Chief Accounting Officer y Controller of Endo International plc since 2020. There are 16 older and no younger executives at Endo International plc. The oldest executive at Endo International plc is Michael Hyatt, 74, who is the Independent Director.
Jack's mailing address filed with the SEC is C/O ENDO INTERNATIONAL PLC, FIRST FL, MINERVA HOUSE, SIMMONSCOURT RD, BALLSBRIDGE, DUBLIN, L2, .
Over the last 11 years, insiders at Endo International plc have traded over $3,455,441 worth of Endo International plc stock and bought 152,347 units worth $3,901,804 . The most active insiders traders include Silva Rajiv De, Paul Campanelli y Shane Cooke. On average, Endo International plc executives and independent directors trade stock every 36 days with the average trade being worth of $12,163. The most recent stock trade was executed by Patrick A Barry on 29 March 2022, trading 59,298 units of ENDP stock currently worth $17,351.
Endo is a specialty pharmaceutical company committed to helping everyone it serves live their best life through the delivery of quality, life-enhancing therapies. Its decades of proven success come from a global team of passionate employees collaborating to bring the best treatments forward. Together, it boldly transforms insights into treatments benefiting those who need them, when they need them.
Endo International plc executives and other stock owners filed with the SEC include: